Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery

Behavioural Brain Research

Volumn 259, Issue , 2014, Pages 50-59

  Mitkari, Bhimashankar ^a   Nitzsche, Franziska ^a   Kerkelä, Erja ^b   Kuptsova, Kristina ^a   Huttunen, Joanna ^a   Nystedt, Johanna ^b   Korhonen, Matti ^b   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Angiogenesis; Behavioral recovery; Cell therapy; Cerebral ischemia; Human bone marrow derived mesenchymal cells; Intravascular delivery

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW DERIVED MESENCHYMAL STROMAL CELL; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN ISCHEMIA; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTERNAL CAROTID ARTERY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYME CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANGIOGENESIS; BEHAVIORAL RECOVERY; CELL THERAPY; CEREBRAL ISCHEMIA; HUMAN BONE MARROW DERIVED MESENCHYMAL CELLS; INTRAVASCULAR DELIVERY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; DISEASE MODELS, ANIMAL; EXTREMITIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUCIN-1; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 84887549825     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.10.030     Document Type: Article

References (61)

1. Bonita R., Solomon N., Broad J.B. Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies. Stroke 1997, 28:898-902.
2. Bliss T., Andres R.H., Steinberg G.K. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010, 37:275-283.
3. England T., Martin P., Bath P.M. Stem cells for enhancing recovery after stroke: a review. Int J Stroke 2009, 4:101-110.
4. Miljan E.A., Sinden J.D. Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther 2009, 11:394-403.
5. Mitkari B., Kerkelä E., Nystedt J., Korhonen M., Huhtala T., Jolkkonen J. Toward a more effective intravascular cell therapy in stroke. Advances in the treatment of ischemic stroke 2012, 141-160. Intech, Croatia. M. Balestrino (Ed.).
6. Borlongan C.V., Glover L.E., Tajiri N., Kaneko Y., Freeman T.B. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 2011, 95:213-228.
7. Komatsu K., Honmou O., Suzuki J., Houkin K., Hamada H., Kocsis J.D. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 2010, 1334:84-92.
8. Gutiérrez-Fernández M., Rodríguez-Frutos B., Alvarez-Grech J., Vallejo-Cremades M.T., Expósito-Alcaide M., Merino J., et al. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience 2011, 175:394-405.
9. Yang B., Strong R., Sharma S., Brenneman M., Mallikarjunarao K., Pei Xi X., et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 2011, 89:833-839.
10. Vasconcelos-dos-Santos A., Rosado-de-Castro P.H., Lopes de Souza S.A., da Costa Silva J., Ramos A.B., Rodriguez de Freitas G., et al. Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: is there a difference in biodistribution and efficacy?. Stem Cell Res 2012, 9:1-8.
11. Suzuki J., Sasaki M., Harada K., Bando M., Kataoka Y., Onodera R., et al. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res 2013, 1497:15-22.
12. Willing A.E., Shahaduzzaman Md. Delivery routes for cell therapy in stroke. Cell-based therapies in stroke 2013, 15-28. Springer, Wien. P. Walczak, J. Jolkkonen (Eds.).
13. Hicks A., Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp (Wars) 2009, 69:1-11.
14. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K., Zigova T., et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35:2390-2395.
15. Newcomb J.D., Craig T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 2006, 15:213-223.
16. Kamiya N., Ueda M., Igarashi H., Nishiyama Y., Suda S., Inaba T., et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 2008, 83:433-437.
17. Misra V., Ritchie M.M., Stone L.L., Low W.C., Janardhan V. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology 2012, 79(13 Suppl 1):S207-S212.
18. Korhonen M., Jolkkonen J. Intravascular cell therapy in stroke patients: where the cells go and what they do. Regen Med 2013, 8:93-95.
19. Mäkinen S., Kekarainen T., Nystedt J., Liimatainen T., Huhtala T., Närvänen A., et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 2006, 1123:207-215.
20. Lappalainen R., Narkilahti S., Huhtala T., Liimatainen T., Suuronen T., Närvänen A., et al. SPECT imaging shows accumulation of stem cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett 2008, 440:246-250.
21. Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabelo J., Young R.G., et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.
22. Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 2010, 30:653-662.
23. Mitkari B., Kerkelä E., Nystedt J., Korhonen M., Huhtala T., Jolkkonen J. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells result in transient localization in the brain after cerebral ischemia in rats. Exp Neurol 2013, 239:158-162.
24. Hicks A., Schallert T., Jolkkonen J. Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 2009, 5:139-140.
25. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57:874-882.
26. Lee J.S., Hong J.M., Moon G.J., Lee P.H., Ahn Y.H., Bang O.Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106. STARTING collaborators.
27. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R., et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011, 134:1790-1807.
28. Bhasin A., Srivastava M.V., Kumaran S.S., Mohanty S., Bhatia R., Bose S., et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra 2011, 1:93-104.
29. Prasad K., Mohanty S., Bhatia R., Srivastava M.V., Garg A., Srivastava A., et al. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J Med Res 2012, 136:221-228.
30. Shen L.H., Li Y., Chen J., Zacharek A., Gao Q., Kapke A., et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007, 27:6-13.
31. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
32. Puurunen K., Jolkkonen J., Sirviö J., Haapalinna A., Sivenius J. An α2-adrenergic antagonist, atipamezole, facilitates recovery after focal cerebral ischemia in rats. Neuropharmacology 2001, 40:597-606.
33. Karhunen H., Virtanen T., Schallert T., Sivenius J., Jolkkonen J. Forelimb use after focal cerebral ischemia in rats treated with an alpha(2)-adrenoceptor antagonist. Pharmacol Biochem Behav 2003, 74:663-669.
34. Schallert T., Woodlee M.T. Orienting and placing. The behavior of the laboratory rat 2005, 129-140. Oxford University Press, New York. I.Q. Whishaw, B. Kolb (Eds.).
35. Butovas S., Lukkarinen J., Virtanen T., Jolkkonen J., Sivenius J. Differential effect of the α2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke. Restor Neurol Neurosci 2001, 18:143-151.
36. Tarte K., Gaillard J., Lataillade J.J., Fouillard L., Becker M., Mossafa H., et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010, 115:1549-1553.
37. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009, 18:683-692.
38. Nystedt J., Anderson H., Tikkanen J., Pietilä M., Hirvonen T., Takalo R., et al. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells. Stem Cells 2013, 31:317-326.
39. Kerkelä E., Hakkarainen T., Mäkelä T., Raki M., Kambur O., Kilpinen L., et al. Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue. Stem Cells Transl Med 2013, 2:510-520.
40. Toma C., Wagner W.R., Bowry S., Schwartz A., Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res 2009, 104:398-402.
41. Zhang Z.G., Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009, 8:491-500.
42. Hayashi T., Noshita N., Sugawara T., Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003, 23:166-180.
43. Zhang L., Li Y., Zhang C., Chopp M., Gosiewska A., Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011, 42:1437-1444.
44. Doyle S., Bennett S., Fasoli S.E., McKenna K.T. Interventions for sensory impairment in the upper limb after stroke. Cochrane Database Syst Rev 2010, 16:CD006331.
45. Freret T., Chazalviel L., Roussel S., Bernaudin M., Schumann-Bard P., Boulouard M. Long-term functional outcome following transient middle cerebral artery occlusion in the rat: correlation between brain damage and behavioral impairment. Behav Neurosci 2006, 120:1285-1298.
46. Fisher M., Feuerstein G., Howells D.W., Hurn P.D., Kent T.A., Savitz S.I., et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
47. Savitz S.I., Chopp M., Deans R., Carmichael S.T., Phinney D., Wechsler L. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 2011, 42:825-829.
48. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
49. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
50. Li J., Ezzelarab M.B., Cooper D.K. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation 2012, 19:273-285.
51. Rossignol J., Boyer C., Thinard R., Remy S., Dugast A.S., Dubayle D., et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009, 13:2547-2558.
52. Janowski M., Walczak P., Date I. Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev 2010, 19:5-16.
53. Baker A.H., Sica V., Work L.M., Williams-Ignarro S., de Nigris F., Lerman L.O., et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. PNAS 2007, 104:3597-3602.
54. Brenneman M., Sharma S., Harting M., Strong R., Cox C.S., Aronowski J., et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 2010, 30:140-149.
55. Janowski M., Lyczek A., Engels C., Xu J., Lukomska B., Bulte J.W., et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 2013, 33:921-927.
56. de Vasconcelos Dos Santos A., da Costa Reis J., Diaz Paredes B., Moraes L., Giraldi-Guimarães A.J., et al. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 2010, 1306:149-158.
57. Boltze J., Schmidt U.R., Reich D.M., Kranz A., Reymann K.G., Strassburger M., et al. Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant 2012, 21:1199-1211.
58. Ishizaka S., Horie N., Satoh K., Fukuda Y., Nishida N., Nagata I. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 2013, 44:720-726.
59. Hiltunen M., Jolkkonen J. Complex pathology in the thalamus following cerebral ischemia. Thalamus: anatomy, functions and disorders 2011, 83-98. Nova Science Publishers Inc. J.L. Song (Ed.).
60. Lees J.S., Sena E.S., Egan K.J., Antonic A., Koblar S.A., Howells D.W., et al. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke 2012, 7:582-588.
61. Sena E.S., van der Worp H.B., Bath P.M., Howells D.W., Macleod M.R. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010, 30:e1000344.